Mylan Pharms. Inc. v. Merck Sharp & Dohme Corp. ; United States Court of Appeals of the Federal Circuit, 2022 50 F.4th 147

Biotechnology Law Report,Volume 41, Issue 6, Page 305-310, December 2022.

Source: Biotechnology Law Report - December 15, 2022 Category: Medical Law Authors: CHRISTOPHER M. HOLMAN Source Type: research